Kelley E. McQueeney

419 total citations
14 papers, 316 citations indexed

About

Kelley E. McQueeney is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Kelley E. McQueeney has authored 14 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Kelley E. McQueeney's work include Protein Tyrosine Phosphatases (8 papers), Galectins and Cancer Biology (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Kelley E. McQueeney is often cited by papers focused on Protein Tyrosine Phosphatases (8 papers), Galectins and Cancer Biology (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Kelley E. McQueeney collaborates with scholars based in United States, Brazil and Japan. Kelley E. McQueeney's co-authors include John S. Lazo, Elizabeth R. Sharlow, Peter Wipf, Joseph M. Salamoun, James C. Burnett, Steven J. Geib, Gregg E. Homanics, Jeffrey S. Isenberg, Mark W. Zimmerman and Bruce R. Pitt and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and The FASEB Journal.

In The Last Decade

Kelley E. McQueeney

14 papers receiving 316 citations

Peers

Countries citing papers authored by Kelley E. McQueeney

Since Specialization

Citations

This map shows the geographic impact of Kelley E. McQueeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelley E. McQueeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelley E. McQueeney more than expected).

Fields of papers citing papers by Kelley E. McQueeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelley E. McQueeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelley E. McQueeney. The network helps show where Kelley E. McQueeney may publish in the future.

Co-authorship network of co-authors of Kelley E. McQueeney

This figure shows the co-authorship network connecting the top 25 collaborators of Kelley E. McQueeney. A scholar is included among the top collaborators of Kelley E. McQueeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelley E. McQueeney. Kelley E. McQueeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Abstract 162: Individualizing treatment using patient derived organoids, BH3 profiling and microfluidics: A proof of concept in a patient with low-grade serous ovarian carcinoma 2023 ·Cancer Research ·(unknown), (unknown), Kelley E. McQueeney, (unknown), (unknown), (unknown), (unknown), Jennifer Curtis, Marisa R. Nucci, (unknown), Cloud P. Paweletz, Joyce F. Liu, Ursula A. Matulonis, Elena V. Ivanova	1
2	Sequential apoptotic and multiplexed proteomic evaluation of single cancer cells 2023 ·Science Advances ·(unknown), Atreyi Mukherji, (unknown), (unknown), Jia‐Ren Lin, (unknown), Kelley E. McQueeney, Jeremy Ryan, Kimmie Ng, Ewa Sicińska, Peter K. Sorger, Anthony Letai, Patrick Bhola	1
3	Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics 2021 ·Science Signaling ·Veerle W. Daniëls, Jason J. Zoeller, Nick van Gastel, Kelley E. McQueeney, Salma Parvin, (unknown), Geoffrey Fell, (unknown), (unknown), Rajat Gupta, Johan Spetz, Patrick Bhola, Jennifer E. Endress, Isaac S. Harris, Emanuel Carrilho, Kristopher A. Sarosiek, David T. Scadden, Joan S. Brugge, Anthony Letai	22
4	Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin 2020 ·Molecular Pharmacology ·(unknown), Adam Boulton, (unknown), (unknown), (unknown), (unknown), Kelley E. McQueeney, John H. Bushweller, W. Minor, Peter Wipf, Elizabeth R. Sharlow, John S. Lazo	10
5	High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors 2020 ·Science Signaling ·Patrick Bhola, Eman Y. Ahmed, Jennifer L. Guerriero, Ewa Sicińska, (unknown), (unknown), Jing Ni, Otari Chipashvili, Timothy Hagan, Marissa S. Pioso, Kelley E. McQueeney, Kimmie Ng, Andrew J. Aguirre, James M. Cleary, (unknown), Alaba Sotayo, Jeremy Ryan, Jean J. Zhao, Anthony Letai	41
6	A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion 2018 ·The FASEB Journal ·Kelley E. McQueeney, Joseph M. Salamoun, (unknown), (unknown), (unknown), (unknown), Elizabeth R. Sharlow, Peter Wipf, John S. Lazo	15
7	New Approaches to Difficult Drug Targets: The Phosphatase Story 2017 ·SLAS DISCOVERY ·John S. Lazo, Kelley E. McQueeney, Elizabeth R. Sharlow	26
8	Small molecule targeting of PTPs in cancer 2017 ·The International Journal of Biochemistry & Cell Biology ·John S. Lazo, Kelley E. McQueeney, James C. Burnett, Peter Wipf, Elizabeth R. Sharlow	30
9	Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor 2017 ·Oncotarget ·Kelley E. McQueeney, Joseph M. Salamoun, James C. Burnett, (unknown), (unknown), Sophie L. Lewandowski, Danielle C. Llaneza, Robert Cornelison, Yunpeng Bai, Zhong‐Yin Zhang, John D. Catravas, Charles N. Landen, Peter Wipf, John S. Lazo, Elizabeth R. Sharlow	33
10	Localization of a Trypanosome Peroxin to the Endoplasmic Reticulum 2016 ·Journal of Eukaryotic Microbiology ·(unknown), Kelley E. McQueeney, (unknown), Meredith T. Morris	6
11	Photooxygenation of an amino-thienopyridone yields a more potent PTP4A3 inhibitor 2016 ·Organic & Biomolecular Chemistry ·Joseph M. Salamoun, Kelley E. McQueeney, (unknown), Steven J. Geib, Elizabeth R. Sharlow, John S. Lazo, Peter Wipf	43
12	Protein-tyrosine Phosphatase 4A3 (PTP4A3) Promotes Vascular Endothelial Growth Factor Signaling and Enables Endothelial Cell Motility 2014 ·Journal of Biological Chemistry ·Mark W. Zimmerman, Kelley E. McQueeney, Jeffrey S. Isenberg, Bruce R. Pitt, (unknown), Gregg E. Homanics, John S. Lazo	44
13	Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents 2014 ·Expert Opinion on Investigational Drugs ·Elizabeth R. Sharlow, Peter Wipf, Kelley E. McQueeney, Ahmet Bakan, John S. Lazo	15
14	Lipin 2 Binds Phosphatidic Acid by the Electrostatic Hydrogen Bond Switch Mechanism Independent of Phosphorylation 2014 ·Journal of Biological Chemistry ·James M. Eaton, (unknown), Robert Lawrence, Kelley E. McQueeney, Salome Boroda, Garrett R. Mullins, (unknown), Brian N. Finck, Judit Villén, Thurl E. Harris	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact